First analysis of the stem cell population showed a significant lower expression of stem cell marker SOX2 in MS organoids compared to control. Stem cell proliferation capacity was assessed by Ki67 marker analysis. It revealed a significant lower Ki67 expression in MS organoids, particularly PPMS, compared to control. We then verified if stem cell differentiation capacity was also disrupted by analyzing mature neuron markers CTIP2 and TBR1 as well as oligodendrocyte marker Olig2. A significant increase of both neuronal markers was detected in PPMS organoids compared to control while a strong decrease of Olig2 expression was detected in MS organoids. Cell cycle inhibitor p21 immunostainings showed a significant reduction of p21 expression in MS samples, particularly in PPMS, suggesting that stem cell proliferation/differentiation dysregulation might be led by p21 pathway independently of the p53 mediated apoptosis pathway.